Miwako Iwai

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors

T. Todo, K. Koike, H. Ijichi, 2022, Molecular therapy oncolytics.

Evaluation of Chemotherapy Regimen Management Practice by Oncology-Specialized and Non-specialized Pharmacists Collaboration.

Y. Komatsu, Y. Takekuma, M. Sugawara, 2021, Biological & pharmaceutical bulletin.

Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12

H. Fukuhara, T. Todo, J. Hou, 2023, Communications Medicine.

Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma

T. Todo, Y. Seto, K. Sugawara, 2021, Molecular therapy oncolytics.

Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models

T. Todo, Minoru Tanaka, Yoshiyuki Mori, 2023, Molecular therapy oncolytics.